Item 1 Comment:
This Amendment No. 7 to Schedule 13D (this "Amendment No. 7") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on March 28, 2022, as amended by Amendment No. 1 to Schedule 13D filed with the SEC on April 26, 2022, Amendment No. 2 to Schedule 13D filed with the SEC on August 12, 2022, Amendment No. 3 to Schedule 13D filed with the SEC on August 24, 2022, Amendment No. 4 to Schedule 13D filed with the SEC on June 14, 2023, Amendment No. 5 to Schedule 13D filed with the SEC on July 14, 2023, and Amendment No. 6 to Schedule 13D filed with the SEC on August 15, 2024 (together with this Amendment No. 7, this "statement") relating to the Common Stock of the Company, the principal executive offices of which are located at 224 Airport Parkway, Suite 550, San Jose, California 95110. Only those items that are hereby reported are amended; all other items reported in the original Schedule 13D, as amended, remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the original Schedule 13D, as amended. |
| Item 3 of the original Schedule 13D, as amended, is hereby amended to add the following language:
On January 3, 2025, the reporting person exercised (a) a warrant to purchase 114,155 shares of common stock par value $0.01 per share (the "Common Stock") of Quantum Corporation (the "Issuer" or the "Company") (CIK: 0000709283) for $54.20 a share, (b) a warrant to purchase 219,970 shares of Common Stock for $26.00 a share, (c) a warrant to purchase 63,435 shares of Common Stock for $6.20 a share, (d) a warrant to purchase 37,536 shares of Common Stock for $6.20 a share, (e) a warrant to purchase 18,750 shares of Common Stock for $6.20 a share, and (f) a warrant to purchase 224,059 shares of Common Stock for $6.20 a share. The reporting person paid the exercise price for each of these warrants on a cashless basis, resulting in the Company withholding an aggregate of 228,195 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 449,710 shares. For more information on the warrants that were exercised on January 3, 2025, please refer to the Form 8-Ks filed by the Issuer on December 28, 2018, June 17, 2020, June 6, 2023, May 29, 2024, July 12, 2024, and August 15, 2024. The securities are held by certain funds and accounts for which the reporting person serves as investment manager, |